A quick read on the stories readers are most likely to want next.
US-Iran negotiations, mediated in Pakistan, have abruptly collapsed after President Trump canceled his envoys' trip, citing Iran's "unchanged negotiating positions." This breakdown has escalated Middle East tensions, with Israel resuming strikes in Lebanon and Iranian state media asserting that a US naval blockade is empowering hardliners and undermining the ceasefire.
A new study from Live Science warns that the crucial Atlantic Meridional Overturning Circulation (AMOC) is dangerously close to collapse, posing severe global climate impacts. This impending breakdown could disrupt carbon recycling and lead to significant warming for Western Europe and the U.S. East Coast.
Mali was rocked by its largest coordinated assault in years on April 25, 2026, as gunmen launched widespread attacks across multiple cities, including the capital Bamako, targeting military barracks, the international airport, and the Defence Minister's residence. While Mali's army declared the situation under control with ongoing sweeping operations, the attacks, which saw the Azawad Liberation Front claim control in some areas, underscore the nation's persistent struggle against various insurgent and separatist groups.
Warner Bros. Discovery shareholders have overwhelmingly approved a massive $111 billion merger with Paramount Skydance, setting the stage for a media conglomerate of unprecedented scale. If regulatory bodies give their consent, this colossal deal would create a dominant force across news, sports, movies, and theme parks, reshaping the entertainment landscape.
The Trump administration has launched a critical new strategy to combat "AI distillation," a sophisticated technique primarily used by adversaries like China to replicate advanced American AI models without needing original training data. This pivotal policy shifts focus from hardware export controls to the software stack, with authorities now evaluating restrictions on closed-source model weights and new reporting requirements to safeguard national security against this growing threat.
In a historic shift, the Trump administration has reclassified cannabis from a Schedule I to a Schedule III substance under federal law, acknowledging its potential medical benefits and lower abuse risk. While this paves the way for increased FDA research into its medicinal uses, it's crucial to note that marijuana remains federally illegal.
